Skip to Main Content
Go to Why Work Here page
Back Bay Life Science Advisors logo

Back Bay Life Science Advisors


About Back Bay Life Science Advisors

Back Bay Life Science Advisors provides life science strategy and investment banking to the global life science industry, including pharma, biotech, MedTech, startups, academia, and investors. From its offices in Boston, Toronto and Frankfurt, Back Bay teams provide consulting services to those on the forefront of the ever-evolving field of life sciences.

Back Bay works with companies of all sizes across the US and global life science markets, across every stage, sector, geography, and therapeutic area. Back Bay strategy and banking teams guide companies on technology and drug development, from planning and initial concept to product commercialization, franchising and licensing, M&A, divestiture, and more.

With headquarters in Boston's Back Bay neighborhood, Back Bay teams are comprised of scientific researchers, biotech executives, physicians, surgeons, bankers and data researchers—experts with proven knowledge and love for new technologies, medicines, and scientific approaches.

Back Bay Life Science Advisors

545 Boylston Street
Boston, MA 20116
Phone: (617) 236-0954

Firm Stats

Co-Founder, Managing Partner, CEO: Jonathan P. Gertler, MD
2021 Employees (All Locations): 30

Major Office Locations

Boston, MA (HQ)
Toronto, Canada

Major Departments & Practices


Biopharma, medtech and healthtech development, product pipeline and lifecycle advisory, integrated with investment banking guidance and execution. Functional practice areas include: 

  • Franchise, business unit & therapeutic area strategy
  • Competitive intelligence
  • Asset & development prioritization
  • Platform implementation
  • Payor/Pricing strategy
  • Contracting strategy
  • Launch & counter-launch strategy
  • Product positioning, branding & messaging
  • Life-cycle management
  • Corporate growth strategy
  • Liquidity & exit planning
  • Mergers, acquisitions & divestitures
  • Private & public company, cross-border capabilities
  • Partnering & strategic alliances
  • Financing support
  • Fairness opinion, valuation
  • Registered broker-dealer
  • Biotech
  • Medtech
  • Healthtech
  • Investors